VMDViemed Healthcare, Inc.
What is the market doing?
Rangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Choppy, but holding above its 200-day average. Overbought (RSI 71). Price is +0% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How VMD is trading
Viemed Healthcare, Inc. is +37% over the past year while the S&P 500 is +18%: 19 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +0.39%
vs 200-day average · close to trend
- RSI (14)
- 71
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 24%
Below its 52-week high
Details›
- Last close2026-10-08
- $9.41
- 1 monthS&P 500 +1.6%
- +7.5%
- 1 yearS&P 500 +18%
- +37%
- 5 yearsS&P 500 +86%
- +70%
- vs 50-day average$9.23
- +1.9%
- 52-week high
- $12.35
- 52-week low
- $6.26
- Annualised volatility
- 37%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$347K
| Year | Return |
|---|---|
| 2026 (year to date) | +27% |
| 2025 | −7.4% |
| 2024 | +2.2% |
| 2023 | +3.8% |
| 2022 | +45% |
| 2021 | −33% |
| 2020 | +25% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 5 of 7 | +0.37% |
| Feb | 7 | 4 of 7 | +1.8% |
| Mar | 7 | 5 of 7 | +6.7% |
| Apr | 7 | 3 of 7 | +5.7% |
| May | 7 | 2 of 7 | −1.1% |
| Jun | 7 | 4 of 7 | +1.6% |
| Jul | 7 | 4 of 7 | +6.2% |
| Aug | 7 | 3 of 7 | −5.2% |
| Sep | 8 | 3 of 8 | −6.0% |
| Oct | 8 | 5 of 8 | +3.9% |
| Nov | 7 | 5 of 7 | +4.2% |
| Dec | 7 | 5 of 7 | −1.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.